@article{2a7863b8f9404c858caed15ad4bb7e1c,
title = "Bortezomib, thalidomide and dexamethasone versus bortezomib, cyclophosphamide and dexamethasone as induction therapy prior to ASCT in multiple myeloma - response to Moreau et al",
keywords = "Bortezomib, cyclophosphamide and dexamethasone, Bortezomib, thalidomide and dexamethasone, Induction therapy, Multiple myeloma",
author = "Merav Leiba and Abraham Avigdor",
year = "2015",
month = feb,
day = "1",
doi = "10.1111/bjh.13125",
language = "English",
volume = "168",
pages = "604--605",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley and Sons Inc.",
number = "4",
}